XML 17 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Revenue $ 3,153,963 $ 2,928,738 $ 2,610,399
Salaries, wages and benefits (including equity-based compensation expense of $37,113, $32,289 and $29,635, respectively) 1,691,024 1,572,330 1,393,434
Professional fees 189,706 176,013 158,013
Supplies 112,713 105,992 100,200
Rents and leases 47,861 46,552 45,462
Other operating expenses 440,788 388,906 349,277
Income from provider relief fund   (6,419) (21,451)
Depreciation and amortization 149,595 132,349 117,769
Interest expense, net 116,368 82,125 69,760
Legal settlements expense   394,181  
Loss on impairment 17,276 9,790  
Gain on sale of property   (9,747)  
Transaction-related expenses 46,753 62,026 23,792
Total expenses 2,812,084 2,954,098 2,236,256
Income from continuing operations before income taxes 341,879 (25,360) 374,143
Provision for (benefit from) income taxes 77,395 (9,699) 94,110
Net (loss) income 264,484 (15,661) 280,033
Net income attributable to noncontrolling interests (8,872) (6,006) (6,894)
Net income (loss) attributable to Acadia Healthcare Company, Inc. $ 255,612 $ (21,667) $ 273,139
Earnings (loss) per share attributable to Acadia Healthcare Company, Inc. stockholders:      
Basic $ 2.79 $ (0.24) $ 3.05
Diluted $ 2.78 $ (0.24) $ 2.98
Weighted-average shares outstanding:      
Basic 91,621 90,949 89,680
Diluted 92,059 90,949 91,555